reference compound lundbeck cmp 1a (Lundbeck)
Structured Review

Reference Compound Lundbeck Cmp 1a, supplied by Lundbeck, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cmp/1a+cmp+lundbeck/pmc12775434-67-25-27
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139"
Article Title: Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139
Journal: Nature Communications
doi: 10.1038/s41467-025-66845-y
Figure Legend Snippet: a A structure of the active GPR139 bound to the reference compound JNJ-63533054 was used in the ultra-large docking screen. b A library of 235 million lead-like compounds from the ZINC database was docked to the orthosteric site using DOCK3.7, and a set of 68 top-ranked compounds were selected for synthesis. c Primary screening of compounds at 10 µM in Ca 2+ mobilization assay. A threshold of 25% Ca 2+ response was used to select compounds for further evaluation. Data represent mean ± SEM of at least three independent experiments performed in triplicates and are normalized to buffer (0%) and 10 µM of the control ( Lundbeck Cmp 1a , 100%).
Techniques Used: Control
Figure Legend Snippet: a Compounds – 5 were pharmacologically characterized for their ability to b stimulate intracellular Ca 2+ mobilization and c inositol monophosphate (IP ) accumulation. Data represent mean ± SEM of at least three independent experiments performed in triplicates and are normalized to buffer (0%) and 10 µM of the control ( Lundbeck Cmp 1a , 100%). The potencies (EC 50 ) determined using the Ca 2+ mobilization assay are shown below each compound structure in ( a ). d Predicted binding modes of compounds – 5 . The receptor is depicted as a cartoon with ligands and selected side chains shown in sticks. Hydrogen bonds are indicated using dashed lines. The structures of the predicted complexes are provided in Supplementary Data .
Techniques Used: Control, Binding Assay
Figure Legend Snippet: a , b Structure of core scaffold (R = aromatic ring) explored in optimization and representative analogs of compound 1 with EC 50 values from the Ca 2+ mobilization assay. The blue and green areas in ( a ) show analogs based on six-membered and five-membered ring substituents, respectively. c The reference GPR139 agonists Lundbeck Cmp 1a, JNJ-63533054, TAK-041 , and compound 1.1 were evaluated for their ability to stimulate intracellular Ca 2+ mobilization and IP 1 accumulation. Data represent mean ± SEM of at least three independent experiments performed in triplicates and are normalized to buffer (0%) and 10 µM of the control ( Lundbeck Cmp 1a , 100%). d Chemical structures comparison of the reference agonists and compound 1.1 .
Techniques Used: Control, Comparison
Related Articles
Activity Assay:Article Title: Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139. Article Snippet: .. Out of the 68 compounds tested for both agonist and antagonist activity at GPR139, 14 compounds (1–14) were found to have agonist activity as they stimulated a calcium mobilization response larger than 25% relative to the response observed for the Article Title: Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139. Article Snippet: .. Following 20 minutes incubation with the compounds added in the first step, in the second step an EC80 concentration (800 nM) of the Article Title: Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139. Article Snippet: Out of the 68 compounds tested for both agonist and antagonist activity at GPR139, 14 compounds (1–14) were found to have agonist activity as they stimulated a calcium mobilization response larger than 25% relative to the response observed for the reference Lundbeck Cmp 1a (Figure 1c, Supplementary Table 2). .. None of the compounds had antagonist activity, as those that inhibited the response of Incubation:Article Title: Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139. Article Snippet: .. Following 20 minutes incubation with the compounds added in the first step, in the second step an EC80 concentration (800 nM) of the Concentration Assay:Article Title: Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139. Article Snippet: .. Following 20 minutes incubation with the compounds added in the first step, in the second step an EC80 concentration (800 nM) of the other:Article Title: Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139. Article Snippet: Data represent mean ± SEM of at least three independent experiments performed in triplicates and are normalized to buffer (0%) and 10 μM of the Functional Assay:Article Title: Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139 Article Snippet: Pharmacological data and statistical analyses were performed in GraphPad Prism v9–10 (Graphpad Software Inc., San Diego, CA), which are also specifically described in the figure and table legends. .. The functional assay responses were normalized to buffer (0%) and Article Title: Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139. Article Snippet: Pharmacological data and statistical analyses were performed in GraphPad Prism v9–10 (Graphpad Software Inc., San Diego, CA), which also are specifically described in the figure and table legends. .. The functional assay responses were normalized to buffer (0%) and Stable Transfection:Article Title: Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139 Article Snippet: Pharmacological data and statistical analyses were performed in GraphPad Prism v9–10 (Graphpad Software Inc., San Diego, CA), which are also specifically described in the figure and table legends. .. The functional assay responses were normalized to buffer (0%) and Article Title: Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139. Article Snippet: Pharmacological data and statistical analyses were performed in GraphPad Prism v9–10 (Graphpad Software Inc., San Diego, CA), which also are specifically described in the figure and table legends. .. The functional assay responses were normalized to buffer (0%) and Activation Assay:Article Title: Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139 Article Snippet: Pharmacological data and statistical analyses were performed in GraphPad Prism v9–10 (Graphpad Software Inc., San Diego, CA), which are also specifically described in the figure and table legends. .. The functional assay responses were normalized to buffer (0%) and Article Title: Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139. Article Snippet: Pharmacological data and statistical analyses were performed in GraphPad Prism v9–10 (Graphpad Software Inc., San Diego, CA), which also are specifically described in the figure and table legends. .. The functional assay responses were normalized to buffer (0%) and Transfection:Article Title: Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139 Article Snippet: Pharmacological data and statistical analyses were performed in GraphPad Prism v9–10 (Graphpad Software Inc., San Diego, CA), which are also specifically described in the figure and table legends. .. The functional assay responses were normalized to buffer (0%) and Article Title: Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139. Article Snippet: Pharmacological data and statistical analyses were performed in GraphPad Prism v9–10 (Graphpad Software Inc., San Diego, CA), which also are specifically described in the figure and table legends. .. The functional assay responses were normalized to buffer (0%) and Produced:Article Title: Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139. Article Snippet: Out of the 68 compounds tested for both agonist and antagonist activity at GPR139, 14 compounds (1–14) were found to have agonist activity as they stimulated a calcium mobilization response larger than 25% relative to the response observed for the reference Lundbeck Cmp 1a (Figure 1c, Supplementary Table 2). .. None of the compounds had antagonist activity, as those that inhibited the response of |